Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fausto Feres

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|March 18, 2015
Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trialsTullio Palmerini, Umberto Benedetto, Letizia Bacchi-Reggiani, et al.
Arquivos Brasileiros De Cardiologia|October 7, 2020
Adapted Catheterization Laboratory Practices during the COVID-19 Pandemic: The Instituto Dante Pazzanese de Cardiologia ProtocolDaniel Chamié, Fernanda Oliveira, Sérgio Braga, et al.
Journal of the American College of Cardiology|March 21, 2015
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysisTullio Palmerini, Diego Sangiorgi, Marco Valgimigli, et al.
Thrombosis and Haemostasis|January 1, 2019
Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTsJeehoon Kang, Kyung Woo Park, Tullio Palmerini, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 19, 2016
Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trialsFadi J Sawaya, Marie-Claude Morice, Marco Spaziano, et al.
Journal of the American College of Cardiology|September 6, 2016
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCIGennaro Giustino, Alaide Chieffo, Tullio Palmerini, et al.
Arquivos Brasileiros De Cardiologia|August 10, 2017
Fausto Feres, Ricardo A Costa, Dimytri Siqueira, et al.
European Heart Journal|December 8, 2022
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trialsFrancesco Costa, Claudio Montalto, Mattia Branca, et al.
European Heart Journal|January 23, 2017
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patientsTullio Palmerini, Diego Della Riva, Umberto Benedetto, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 16, 2026
Transcatheter valve-in-valve versus redo-surgical valve replacement for mitral bioprosthetic valve dysfunction: rationale and design of the SURVIV randomised trialDimytri A Siqueira, Alexandre A C Abizaid, Auristela A Ramos, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|March 18, 2015
Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trialsTullio Palmerini, Umberto Benedetto, Letizia Bacchi-Reggiani, et al.
Arquivos Brasileiros De Cardiologia|October 7, 2020
Adapted Catheterization Laboratory Practices during the COVID-19 Pandemic: The Instituto Dante Pazzanese de Cardiologia ProtocolDaniel Chamié, Fernanda Oliveira, Sérgio Braga, et al.
Journal of the American College of Cardiology|March 21, 2015
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysisTullio Palmerini, Diego Sangiorgi, Marco Valgimigli, et al.
Thrombosis and Haemostasis|January 1, 2019
Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTsJeehoon Kang, Kyung Woo Park, Tullio Palmerini, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 19, 2016
Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trialsFadi J Sawaya, Marie-Claude Morice, Marco Spaziano, et al.
Journal of the American College of Cardiology|September 6, 2016
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCIGennaro Giustino, Alaide Chieffo, Tullio Palmerini, et al.
Arquivos Brasileiros De Cardiologia|August 10, 2017
Fausto Feres, Ricardo A Costa, Dimytri Siqueira, et al.
European Heart Journal|December 8, 2022
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trialsFrancesco Costa, Claudio Montalto, Mattia Branca, et al.
European Heart Journal|January 23, 2017
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patientsTullio Palmerini, Diego Della Riva, Umberto Benedetto, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 16, 2026
Transcatheter valve-in-valve versus redo-surgical valve replacement for mitral bioprosthetic valve dysfunction: rationale and design of the SURVIV randomised trialDimytri A Siqueira, Alexandre A C Abizaid, Auristela A Ramos, et al.
Pageof 13